This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Passioura, T. Articles by Symonds, G. Search for Related Content PubMed PubMed Citation Articles by Passioura, T. Articles by Symonds, G.

N-Ras–Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1

¹ School of Medical Sciences, The University of New South Wales, Kensington and ² Children's Cancer Institute Australia, Randwick, Sydney, New South Wales, Australia

Requests for reprints: Geoff Symonds, Locked Bag 4555, Strawberry Hills, New South Wales 2012, Australia. Phone: 128-396-5800; Fax: 128-396-5811; E-mail: gsymonds{at}MEDAU.JNJ.com.

Activating mutations in ras oncogenes occur at high frequency in human malignancies and expression of activated ras in immortalized cells lines is generally transforming. However, somewhat paradoxically, ectopic expression of ras in some myeloid cell lines has been shown to induce growth suppression associated with up-regulation of the cyclin-dependent kinase inhibitor p21^CIP1/WAF1 in a p16^INK4a, p15^INK4b, and p53 independent fashion. We have used cDNA array technology to compare the expression profile induced by activated N-ras (N-rasG13R) in growth-suppressed myeloid cells with that induced in myeloid cells, which are transformed by N-rasG13R. The expression profile induced in growth suppressed cells was consistent with differentiation and included the up-regulation of the transcription factor IFN regulatory factor-1 (IRF-1), a known transcriptional activator of p21^CIP/WAF1 expression and a target of oncogenic mutations associated with myeloid leukemia. Antisense suppression of IRF-1 prevented N-rasG13R–associated growth arrest and up-regulation of p21^CIP1/WAF1. These results define a novel tumor suppressive response to oncogenic signaling and provide a mechanistic link between growth suppression and differentiation in myeloid cells.

Key Words: ras • IRF-1 • myeloid differentiation • AML • MDS

This article has been cited by other articles:

				T. A. Konrad, A. Karger, H. Hackl, I. Schwarzinger, I. Herbacek, and R. Wieser Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes J. Leukoc. Biol., October 1, 2009; 86(4): 813 - 822. [Abstract] [Full Text] [PDF]

				V. Narayan, M. Eckert, A. Zylicz, M. Zylicz, and K. L. Ball Cooperative Regulation of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by Core Components of the Molecular Chaperone Machinery J. Biol. Chem., September 18, 2009; 284(38): 25889 - 25899. [Abstract] [Full Text] [PDF]

				A. Kroger, A. Stirnweiss, J. E. Pulverer, K. Klages, M. Grashoff, J. Reimann, and H. Hauser Tumor Suppression by IFN Regulatory Factor-1 Is Mediated by Transcriptional Down-regulation of Cyclin D1 Cancer Res., April 1, 2007; 67(7): 2972 - 2981. [Abstract] [Full Text] [PDF]

				C. Petti, A. Molla, C. Vegetti, S. Ferrone, A. Anichini, and M. Sensi Coexpression of NRASQ61R and BRAFV600E in Human Melanoma Cells Activates Senescence and Increases Susceptibility to Cell-Mediated Cytotoxicity. Cancer Res., July 1, 2006; 66(13): 6503 - 6511. [Abstract] [Full Text] [PDF]

				Z. Hao, X. Li, T. Qiao, J. Zhang, X. Shao, and D. Fan Distribution of CIAPIN1 in Normal Fetal and Adult Human Tissues J. Histochem. Cytochem., April 1, 2006; 54(4): 417 - 426. [Abstract] [Full Text] [PDF]